Literature DB >> 20571037

Adaptor protein Lnk inhibits c-Fms-mediated macrophage function.

Saskia Gueller1, Helen S Goodridge, Birte Niebuhr, Hongtao Xing, Maya Koren-Michowitz, Hubert Serve, David M Underhill, Christian H Brandts, H Phillip Koeffler.   

Abstract

The M-CSFR (c-Fms) participates in proliferation, differentiation, and survival of macrophages and is involved in the regulation of distinct macrophage functions. Interaction with the ligand M-CSF results in phosphorylation of tyrosine residues on c-Fms, thereby creating binding sites for molecules containing SH2 domains. Lnk is a SH2 domain adaptor protein that negatively regulates hematopoietic cytokine receptors. Here, we show that Lnk binds to c-Fms. Biological and functional effects of this interaction were examined in macrophages from Lnk-deficient (KO) and WT mice. Clonogenic assays demonstrated an elevated number of M-CFUs in the bone marrow of Lnk KO mice. Furthermore, the M-CSF-induced phosphorylation of Akt in Lnk KO macrophages was increased and prolonged, whereas phosphorylation of Erk was diminished. Zymosan-stimulated production of ROS was increased dramatically in a M-CSF-dependent manner in Lnk KO macrophages. Lastly, Lnk inhibited M-CSF-induced migration of macrophages. In summary, we show that Lnk binds to c-Fms and can blunt M-CSF stimulation. Modulation of levels of Lnk in macrophages may provide a unique therapeutic approach to increase innate host defenses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571037      PMCID: PMC3218676          DOI: 10.1189/jlb.0309185

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  41 in total

1.  Expression of c-Myc in response to colony-stimulating factor-1 requires mitogen-activated protein kinase kinase-1.

Authors:  M Cheng; D Wang; M F Roussel
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

2.  Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production.

Authors:  David M Underhill; Eddie Rossnagle; Clifford A Lowell; Randi M Simmons
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

3.  CSF-1 and PI 3-kinase regulate podosome distribution and assembly in macrophages.

Authors:  Ann P Wheeler; Stephen D Smith; Anne J Ridley
Journal:  Cell Motil Cytoskeleton       Date:  2006-03

Review 4.  The cell biology of macrophage activation.

Authors:  D O Adams; T A Hamilton
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

5.  Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice.

Authors:  Hideo Ema; Kazuhiro Sudo; Jun Seita; Azusa Matsubara; Yohei Morita; Mitsujiro Osawa; Kiyoshi Takatsu; Satoshi Takaki; Hiromitsu Nakauchi
Journal:  Dev Cell       Date:  2005-06       Impact factor: 12.270

6.  Modulation of interleukin-1 beta RNA in monocytic cells infected with human immunodeficiency virus-1.

Authors:  K Yamato; Z el-Hajjaoui; K Simon; H P Koeffler
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

7.  Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B.

Authors:  T W Kelley; M M Graham; A I Doseff; R W Pomerantz; S M Lau; M C Ostrowski; T F Franke; C B Marsh
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

8.  Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.

Authors:  Wei Tong; Jing Zhang; Harvey F Lodish
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

9.  Direct observation and quantification of macrophage chemoattraction to the growth factor CSF-1.

Authors:  S E Webb; J W Pollard; G E Jones
Journal:  J Cell Sci       Date:  1996-04       Impact factor: 5.285

10.  Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse.

Authors:  M G Cecchini; M G Dominguez; S Mocci; A Wetterwald; R Felix; H Fleisch; O Chisholm; W Hofstetter; J W Pollard; E R Stanley
Journal:  Development       Date:  1994-06       Impact factor: 6.868

View more
  11 in total

1.  Genetic loss of SH2B3 in acute lymphoblastic leukemia.

Authors:  Arianne Perez-Garcia; Alberto Ambesi-Impiombato; Michael Hadler; Isaura Rigo; Charles A LeDuc; Kara Kelly; Chaim Jalas; Elisabeth Paietta; Janis Racevskis; Jacob M Rowe; Martin S Tallman; Maddalena Paganin; Giuseppe Basso; Wei Tong; Wendy K Chung; Adolfo A Ferrando
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

Review 2.  The function of SH2B3 (LNK) in the kidney.

Authors:  Gregory Blass; David L Mattson; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-20

3.  SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.

Authors:  Maya Koren-Michowitz; Sigal Gery; Takayuki Tabayashi; Dechen Lin; Rocio Alvarez; Arnon Nagler; H Phillip Koeffler
Journal:  Br J Haematol       Date:  2013-04-17       Impact factor: 6.998

Review 4.  CSF-1 receptor signaling in myeloid cells.

Authors:  E Richard Stanley; Violeta Chitu
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

5.  Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3.

Authors:  De-Chen Lin; Tong Yin; Maya Koren-Michowitz; Ling-Wen Ding; Saskia Gueller; Sigal Gery; Takayuki Tabayashi; Ulla Bergholz; Julhash U Kazi; Lars Rönnstrand; Carol Stocking; H Phillip Koeffler
Journal:  Blood       Date:  2012-08-31       Impact factor: 22.113

Review 6.  The role of small adaptor proteins in the control of oncogenic signalingr driven by tyrosine kinases in human cancer.

Authors:  Cécile Naudin; Clément Chevalier; Serge Roche
Journal:  Oncotarget       Date:  2016-03-08

7.  Specific disruption of Lnk in murine endothelial progenitor cells promotes dermal wound healing via enhanced vasculogenesis, activation of myofibroblasts, and suppression of inflammatory cell recruitment.

Authors:  Jun Hee Lee; Seung Taek Ji; Jaeho Kim; Satoshi Takaki; Takayuki Asahara; Young-Joon Hong; Sang-Mo Kwon
Journal:  Stem Cell Res Ther       Date:  2016-10-28       Impact factor: 6.832

8.  Bioinformatic gene analysis for possible biomarkers and therapeutic targets of hypertension-related renal cell carcinoma.

Authors:  Wenjie Huang; Ke Wu; Ruoyu Wu; Zhiguo Chen; Wei Zhai; Junhua Zheng
Journal:  Transl Androl Urol       Date:  2020-12

9.  LNK (SH2B3): paradoxical effects in ovarian cancer.

Authors:  L-W Ding; Q-Y Sun; D-C Lin; W Chien; N Hattori; X-M Dong; S Gery; M Garg; N B Doan; J W Said; J-F Xiao; H Yang; L-Z Liu; X Meng; R Y-J Huang; K Tang; H P Koeffler
Journal:  Oncogene       Date:  2014-04-07       Impact factor: 9.867

Review 10.  The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis.

Authors:  Rhiannon Morris; Liesl Butler; Andrew Perkins; Nadia J Kershaw; Jeffrey J Babon
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.